Drugs Archives - Page 45 of 65 - ��ýҕ�l Health News

Podcast: KHN’s ‘What The Health?’ Reading The Tea Leaves In Blue Wave’s Wake

In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHN’s Jay Hancock about the latest “Bill of the Month.”

Nov. 29, 2018

Pharma Cash To Congress

Democrats Winning Key Leadership Jobs Have Taken Millions From Pharma

Top House Republican also received more than $1 million from drugmakers since 2007.

By Emmarie Huetteman

Nov. 29, 2018

Fish Oil Drug Looks Heart-Healthy. Just Don’t Swallow It Hook, Line And Sinker.

The complete findings of a recent study show the FDA-approved drug Vascepa reduced the likelihood of cardiovascular death, stroke and other heart conditions in some patients. But science didn’t find the same promise for over-the-counter fish oil supplements when tested in healthy people.

By Shefali Luthra

Nov. 20, 2018

New Congress To Tackle Burning Health Care Issues, Including Drug Prices

KHN’s Sarah Jane Tribble discusses the twists and turns with CBS News.

Nov. 16, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Nov. 16, 2018

Podcast: KHN’s ‘What The Health?’ Doctors, Guns And Lame Ducks

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss how the Democrats’ takeover of the House and other results from the Nov. 6 elections might affect health care, and what Congress may have in store for the lame-duck session.

Nov. 15, 2018

Childbirth In The Age Of Addiction: New Mom Worries About Maintaining Sobriety

For mothers in recovery from opioid addiction, narcotic pain relief during and after delivery can put sobriety at risk.

By April Dembosky, KQED

Nov. 14, 2018

Fish Oil And Vitamin D Pills No Guard Against Cancer Or Serious Heart Trouble

And new study finds no reason to get routine vitamin D tests, researchers say.

By Liz Szabo

Nov. 10, 2018

Podcast: KHN’s ‘What The Health?’ Split Decision On Health Care

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Rebecca Adams of CQ Roll Call and Joanne Kenen of Politico discuss the Trump administration’s new birth control coverage rules and the potential impact of the midterm election results on health policy.

Nov. 8, 2018

2018 Elections

House Dems In New Seats Of Power Will Steer Health Policy, Attack Drug Prices

Democrats, who have a history of championing the Affordable Care Act and railing about drug prices, will now chair several house committees.

By Emmarie Huetteman

Nov. 7, 2018

Heart Drug Spotlights Troubling Trends In Drug Marketing

Critics worry the marketing of Vascepa, a purified fish oil product, could prove a fish story.

By Shefali Luthra

Nov. 2, 2018

Pricey Precision Medicine Often Financially Toxic For Cancer Patients

Medical treatments targeting the DNA in tumor cells are celebrated, but insurers often won’t cover the skyrocketing cost.

By Liz Szabo

Nov. 1, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Oct. 26, 2018

Trump Adds A Global Pricing Plan To Wide Attack On Drug Prices, But Doubts Persist

Over the past five months, the Trump administration has proposed a series of reforms to lower the cost of prescription drugs.

By Sarah Jane Tribble

Oct. 26, 2018

Podcast: KHN’s ‘What The Health?’ Trump, GOP Fight Back On Health Care

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss a flurry of proposals from the Trump administration on prices Medicare pays for drugs and the Affordable Care Act.

Oct. 25, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Oct. 19, 2018

Podcast: KHN’s ‘What The Health?’ Republicans’ Preexisting Political Problem

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Stephanie Armour of The Wall Street Journal and Joanne Kenen of Politico discuss how protections for people with preexisting conditions have become a top issue in the elections, Trump administration efforts to make prescription drug prices more public and the start of Medicare’s annual open-enrollment period. Plus, Rovner interviews California Attorney General Xavier Becerra.

Oct. 18, 2018

Pharma Cash To Congress

Drugmakers Funnel Millions To Lawmakers; A Few Dozen Get $100,000-Plus

Drugmakers' contributions to lawmakers have peaked as surging drug prices emerge as a hot-button political issue. In the past decade, Congress has received nearly $79 million from 68 pharma PACs, run by employees of companies that make drugs treating everything from cancer to erectile dysfunction.

By Emmarie Huetteman and Sydney Lupkin

Oct. 16, 2018